# Topical Application of Cocaine HCl 4%, or 10%, or Placebo Solution in Local (Topical) Anesthesia

> **NCT02500836** · PHASE3 · COMPLETED · sponsor: **Lannett Company, Inc.** · enrollment: 646 (actual)

## Conditions studied

- Any Ear Nose or Throat Conditions
- With Identified Need for a Diagnostic Procedure or Surgery on or Through the Mucous Membranes of the Nasal Cavities

## Interventions

- **DRUG:** Cocaine HCl 4% Topical Solution
- **DRUG:** Cocaine HCl 10% Topical Solution
- **DRUG:** Placebo Topical Solution

## Key facts

- **NCT ID:** NCT02500836
- **Lead sponsor:** Lannett Company, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-09
- **Primary completion:** 2016-07
- **Final completion:** 2016-07
- **Target enrollment:** 646 (ACTUAL)
- **Last updated:** 2017-05-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02500836

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02500836, "Topical Application of Cocaine HCl 4%, or 10%, or Placebo Solution in Local (Topical) Anesthesia". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02500836. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*